2 results
Approved WMOCompleted
Primary: progression-free survival in the GSK1120212-group in comparison with the docetaxel group. Secondary: safety and tolerability, response rate, duration of response, overall survival, PK.
Approved WMOCompleted
With this study we compare the BHR and a conventional THP in a young and active patient group, to confirm that for this specific patient group and under favorable implantation circumstances, the BHR is a better solution regarding the post-op…